AIG
KITE

American International Group’s Kite Pharma, Inc. KITE Stock Holding History

American International Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-32,451
Closed -$5.83M – 3070
2017
Q3 		$5.83M Buy
32,451
+2,120
+7% +$295K 0.02% 650
2017
Q2 		$3.14M Buy
30,331
+6,600
+28% +$539K 0.01% 865
2017
Q1 		$1.86M Buy
23,731
+1,198
+5% +$74.1K 0.01% 953
2016
Q4 		$1.01M Sell
22,533
-59
-0.3% -$2.89K ﹤0.01% 1226
2016
Q3 		$1.26M Buy
22,592
+34
+0.2% +$1.89K 0.01% 1095
2016
Q2 		$1.13M Buy
22,558
+5,518
+32% +$271K ﹤0.01% 1109
2016
Q1 		$782K Hold
17,040
– – ﹤0.01% 1659
2015
Q4 		$1.05M Sell
17,040
-2,769
-14% -$195K ﹤0.01% 1479
2015
Q3 		$1.1M Buy
19,809
+8
+0% +$503 ﹤0.01% 1388
2015
Q2 		$1.21M Buy
19,801
+10,975
+124% +$626K ﹤0.01% 1445
2015
Q1 		$509K Sell
8,826
-104
-1% -$6.97K ﹤0.01% 2150
2014
Q4 		$515K Buy
+8,930
New +$376K ﹤0.01% 2114

American International Group's KITE Position: Q4 2017 in Review

American International Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 32,451 shares — an estimated $5.83M sold.

American International Group first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $5.83M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • American International Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • American International Group sold 32,451 Kite Pharma, Inc. shares in Q4 2017, an estimated $5.83M.
  • American International Group first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • American International Group's Kite Pharma, Inc. position peaked at $5.83M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on American International Group's 13F filing for Q4 2017, filed 9 Feb 2018.